TP53 and lung carcinoma: In contrast, in lung cancer, mutations have been found in oncogenes such as TP53, EGFR, and KRAS, associated with carcinogen exposure during smoking, and hypoxia-induced activation of HIF-1α, promoting angiogenesis, is more frequent [16,17].